GlassScriptPhysician profile
Rupa Patel
NPI 1770863789
$2,366.80
in general payments reported to CMS, 2019-2025
25 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $495 · 2022: $466 · 2023: $516 · 2024: $578 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $362.94 | 2021-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $328.39 | 2021-2025 | Camzyos |
| Novo Nordisk INC | $272.05 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $202.72 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $147.63 | 2023-2024 | Farxiga |
| Amgen INC. | $125.89 | 2022-2025 | Repatha |
| Abiomed | $116.87 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $113.99 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.04 | 2023-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $95.96 | 2024 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.34 | 2022-2023 | Lifevest |
| Esperion Therapeutics, INC. | $73.42 | 2021-2024 | Nexletol |
| Cvrx, INC. | $66.11 | 2024-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $44.48 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $33.11 | 2024 | Arcalyst |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $26.69 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $25.66 | 2024 | |
| Abbott Laboratories | $22.28 | 2023 | Amplatzer Amulet |
| Atricure, INC. | $21.45 | 2024 | |
| Philips North America LLC | $18.64 | 2025 | Mcot |
| Bayer Healthcare Pharmaceuticals INC. | $17.73 | 2025 | |
| Daiichi Sankyo INC. | $17.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $15.57 | 2025 | Optimizer |
| Kestra Medical Technology Services, INC. | $13.96 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $13.88 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.